Li Tao

11 Huaihai Road
Yangzhou, 225009, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Editorial: Exploring adverse drug reactions: monitoring, mechanism, intervention, and resolution.

Editorial: Exploring adverse drug reactions: monitoring, mechanism, intervention, and resolution.

Journal: Frontiers in medicine

Published: January 29, 2026

Compare the prognosis of pancreatic cancer patients with different treatment modalities and use machine learning methods to build predictive models.

Compare the prognosis of pancreatic cancer patients with different treatment modalities and use machine learning methods to build predictive models.

Journal: Frontiers in medicine

Published: May 15, 2025

Cell Type-Preferential Expression of Peptidylarginine Deiminase 4 and p53-Dependent Therapeutic Vulnerabilities in Gastric Cancer.

Cell Type-Preferential Expression of Peptidylarginine Deiminase 4 and p53-Dependent Therapeutic Vulnerabilities in Gastric Cancer.

Journal: Digestive diseases and sciences

Published: May 19, 2024

Nudge theories and strategies influencing adult health behaviors and outcomes in COPD management: a systematic review.

Nudge theories and strategies influencing adult health behaviors and outcomes in COPD management: a systematic review.

Journal: Frontiers in public health

Published: March 21, 2024

Structurally diverse deformed phenanthrenes from Strophioblachia fimbricalyx with cytotoxic activities by inducing cell apoptosis.

Structurally diverse deformed phenanthrenes from Strophioblachia fimbricalyx with cytotoxic activities by inducing cell apoptosis.

Journal: Phytochemistry

Published: December 15, 2023

Celastrus orbiculatus extract suppresses gastric cancer stem cells through the TGF-β/Smad signaling pathway.

Celastrus orbiculatus extract suppresses gastric cancer stem cells through the TGF-β/Smad signaling pathway.

Journal: Journal of natural medicines

Published: February 23, 2023

Agrimoniin is a dual inhibitor of AKT and ERK pathways that inhibit pancreatic cancer cell proliferation.

Agrimoniin is a dual inhibitor of AKT and ERK pathways that inhibit pancreatic cancer cell proliferation.

Journal: Phytotherapy research : PTR

Published: January 08, 2023

PTBP1 drives c-Myc-dependent gastric cancer progression and stemness.

PTBP1 drives c-Myc-dependent gastric cancer progression and stemness.

Journal: British journal of cancer

Published: September 15, 2022

Chk1 inhibition-induced BRCAness synergizes with olaparib in p53-deficient cancer cells.

Chk1 inhibition-induced BRCAness synergizes with olaparib in p53-deficient cancer cells.

Journal: Cell cycle (Georgetown, Tex.)

Published: August 12, 2022

Correlation of gemcitabine sensitization by Chk1 inhibition with p53 status.

Correlation of gemcitabine sensitization by Chk1 inhibition with p53 status.

Journal: Journal of chemotherapy (Florence, Italy)

Published: May 31, 2022

Salvianolic acid B, a new type I IRE1 kinase inhibitor, abrogates AngII-induced angiogenesis by interacting with IRE1 in its active conformation.

Salvianolic acid B, a new type I IRE1 kinase inhibitor, abrogates AngII-induced angiogenesis by interacting with IRE1 in its active conformation.

Journal: Clinical and experimental pharmacology & physiology

Published: April 13, 2022

Corrigendum: COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis.

Corrigendum: COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis.

Journal: Frontiers in pharmacology

Published: December 09, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026